The FDA said in a statement that it had determined that one of the two approved vaccines, Ixchiq (Valneva SE), which contains ...

By Stephanie Brown HealthDay ReporterMONDAY, Aug. 25, 2025 (HealthDay News) -- The U.S. Food and Drug Administration is ...

Shares of French drugmaker Valneva slumped more than 20% on Monday after the U.S. Food and Drug Administration suspended the ...

CDC warns travelers to China about enhanced chikungunya risk in Guangdong Province, recommending vaccines, insect repellent and protective clothing.

The FDA has made the decision to suspend the biologics license for Valneva’s chikungunya vaccine Ixchiq following additional reports of chikungunya-like illness.

Valneva must immediately cease U.S. shipments and sales of Ixchiq, a vaccine for chikungunya virus. The FDA recently lifted a ...

US health authorities have suspended the license for the Ixchiq vaccine against the chikungunya virus following reports of ...

The agency said it had become aware of more reports of serious adverse events, leading center director Vinay Prasad to ...

The FDA suspends Ixchiq, the only approved chikungunya vaccine, over safety concerns, impacting its availability in the U.S.

Valneva (VALN) stock in focus as the FDA suspends its chikungunya vaccine Ixchiq due to safety issues, including deaths. Read ...

Less than three weeks after lifting a pause on the use of Valneva’s chikungunya vaccine Ixchiq, the FDA has done an ...